Diagnostic Services hero image

Diagnostic Services

We provide diagnostic, prognostic, and predictive answers to cancer testing that empowers the best possible care for your patients.

path scope

Personalized patient care is rooted in precision oncology.

Sophisticated diagnostic testing is how we deliver precision oncology to you and your patients. Our comprehensive testing menu of over 650 tests covers all major testing methodologies – flow cytometry, FISH, cytogenetics, and targeted or broad-panel DNA- and RNA-based next-generation sequencing (NGS) – for tissue-based and liquid biopsy testing of solid tumor and hematologic cancers. NGS provides the resolution to detect targetable biomarkers and identify the driving mechanism behind your patients’ cancer, with the added benefit of revealing clinical trial opportunities and beyond. Identifying the right test doesn’t have to be complicated. We simplify your ordering process with expertly designed single-order products, like NeoTYPE® Cancer Profiles – a unique offering that ranges from broad spectrum pan-tumor profiling to disease-specific testing, centered on NGS.

NEW

KRAS G12C

One of the most prevalent biomarkers in non-small cell lung cancer (NSCLC).

KRAS mutations are common oncogenic drivers in NSCLC and generally exclusive of other driver mutations in genes such as EGFR, ALK, and ROS1.4 KRAS mutations are often early truncal mutations that can persist during disease progression.

InVisionFirst®-Lung

InVisionFirst®-Lung
ctDNA liquid biopsy for advanced non-small cell lung cancer (NSCLC)

InVisionFirst®-Lung liquid biopsy is a focused 37-gene panel that covers the guideline recommended biomarkers to help inform diagnosis and progression of NSCLC patients.

NeoTYPE® Cancer Profiles

NeoTYPE® Cancer Profiles for hematologic and solid tumor malignancies

NeoTYPE® Cancer Profiles offer two unique levels of molecular profiling services that center on NGS based testing; both broad and targeted profiles are available.

COMPASS®

COMPASS® Hematopathology Services

Clear and comprehensive diagnostic solution is the foundation for the best patient care.
COMPASS® is a streamlined, board-certified hematopathologist directed approach that provides an accurate, actionable and definitive diagnosis for complex hematologic malignancies.

 

KRAS G12C
InVisionFirst®-Lung
NeoTYPE® Cancer Profiles
COMPASS®

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients